1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About SI-BONE Inc

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a source of pain in 15% to 30% of chronic low back pain. The iFuse Implant™, commercially available since 2009, is the only SI joint fusion device supported by multiple prospective clinical studies, including two randomized controlled trials, showing improved pain, patient function and quality of life resulting from treatment. There are over 90 peer-reviewed publications demonstrating the safety, durable effectiveness, and biomechanical and economic benefits unique to the iFuse Implant ( This body of evidence has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
Jeffrey Dunn

471 El Camino Real Ste 101
Santa Clara, California 95050-4482
Phone: 14082070700


SI-BONE, Inc. Announces iFuse Bedrock Granite Implant System Compatibility with Certain Medtronic CD Horizon Solera 5.5/6.0 System Rods
Sep 05, 2023 20:09pm

SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD Horizon Solera 5.5mm and 6.0mm posterior spinal fixation rods manufactured by Medtronic Sofamor Danek USA Inc., a division of Medtronic plc, meet SI-BONE’s criteria for compatibility with

SI-BONE: Another Record Quarter, Reinvesting For Future Growth, Reiterate Buy
Aug 31, 2023 20:28pm

SI-BONE, Inc. presents compelling long-term value with robust growth in unit economics, high gross profits, and attractive valuation upside. Read more on SIBN.

Source:Seeking Alpha
Morgan Stanley bullish on SI-Bone, downgrades Stevanato, Integra, Agiliti
Aug 27, 2023 21:16pm

Morgan Stanley has added SI-Bone to its list of top medtech picks in the small-to-medium cap space, but downgraded Stevanato, Sight Sciences, Integra and Agiliti. Read more here.

Source:Seeking Alpha
Truist Securities maintains Si-Bone at ''buy'' with a price target of $31.00
Aug 08, 2023 11:31am
SI-BONE, Inc. (SIBN) Q2 2023 Earnings Call Transcript
Aug 08, 2023 01:40am

SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ETCompany ParticipantsSaqib Iqbal - Senior Director, FP&A and Investor RelationsLaura Francis…

Source:Seeking Alpha
SI-BONE GAAP EPS of -$0.30 beats by $0.10, revenue of $33.3M beats by $1.95M
Aug 07, 2023 20:54pm

SI-BONE press release (SIBN): Q2 GAAP EPS of -$0.30 beats by $0.10.Revenue of $33.3M (+30.1% Y/Y) beats by $1.95M.Shares +4.48%.Based on the strength of performance in the…

Source:Seeking Alpha
Earnings Preview: SI-BONE
Aug 04, 2023 17:01pm

SI-BONE (NASDAQ: SIBN ) is set to give its latest quarterly earnings report on Monday, 2023-08-07. Here''s what investors need to know before the announcement. Analysts estimate that SI-BONE will report an earnings per share (EPS) of $-0.41. SI-BONE bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on